Search

everythinglearnresearchcommunity

for

Search:↓

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Overt hyperthyroidism is the most common thyroid disorder, especially in women.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Insulin resistance and nesfatin-1 are linked to acne severity.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Alopecia areata mainly affects men aged 21-40 and is linked to autoimmune issues, thyroid problems, and inflammation.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.